Solid Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 13.3, 142.17, 367.84, 591.51 ], "ebit_estimate": [ -237.34, -257.42, -178.85, -19.35, 131.7 ], "ebitda_estimate": [ -238.56, -268.94, -227.46, null, null ], "net_income_estimate": [ -231.54, -254.13, -166.96, -3.13, 163.2 ], "per_share_eps_estimate": [ -1.96, -1.96, -1.35, 0.02, 1.17 ], "eps_nri_estimate": [ -1.98, -1.96, -1.38, 0.02, 1.17 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.5, 0.82, null, null, null ], "pretax_income_estimate": [ -229.56, -251.61, -182.91, -47.61, 102.03 ], "operating_cash_flow_per_share_estimate": [ -1.52, -1.44, null, null, null ], "roa_estimate": [ -78.4, -122.2, -28.3, null, null ], "roe_estimate": [ -96.03, -111.31, -38.64, null, null ], "gross_margin_estimate": [ 96.1, 96.2, 75, 75, 75 ], "operating_cash_flow_estimate": [ -166.91, -158.13, null, null, null ], "pettm_estimate": [ 0, 0, 0, 520.25, 8.89 ], "long_term_growth_rate_mean": 10.57, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 10.93, "future_eps_nri_estimate_growth": 10.57, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -9.01, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 25.83, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, 0.59, 3.69, 23.72 ], "ebit_estimate": [ -57.4, -59.68, -61.52, -60.96, -61.73, -64.27, -62.84, null ], "ebitda_estimate": [ -55.36, -56.81, -58.94, null, null, null, null, null ], "net_income_estimate": [ -55.98, -58.45, -60.37, -59.21, -59.98, -62.52, -61.09, null ], "per_share_eps_estimate": [ -0.46, -0.48, -0.49, -0.5, -0.5, -0.52, -0.49, -0.57 ], "eps_nri_estimate": [ -0.47, -0.48, -0.49, -0.51, -0.51, -0.53, -0.5, -0.57 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 0.97, 0.5, 0.03, null, null, null, null, null ], "pretax_income_estimate": [ -44.45, -57.83, -59.3, -59.21, -59.98, -62.52, -61.09, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -58.13, -61.99, -76.14, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 10.57, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 10.93, "future_eps_nri_estimate_growth": 10.57, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -9.01, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 25.83, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }